Cartilage Degeneration Market Forecast 2024-2033: Projected CAGR, Key Drivers, And Trends

Overview and Scope
Cartilage degeneration refers to the gradual deterioration or breakdown of cartilage tissue, a smooth, flexible connective tissue covering the ends of bones in joints. Cartilage is a cushion that allows for smooth joint movement by reducing bone friction. Cartilage degeneration leads to pain, stiffness, and decreased joint function.

Sizing and Forecast
The cartilage degeneration market size has grown strongly in recent years. It will grow from $11.88 billion in 2023 to $12.63 billion in 2024 at a compound annual growth rate (CAGR) of 6.3%.  The  growth in the historic period can be attributed to aging population, joint injuries, obesity epidemic, sports injuries, limited self-repair capacity.

The cartilage degeneration market size is expected to see strong growth in the next few years. It will grow to $15.64 billion in 2028 at a compound annual growth rate (CAGR) of 5.5%.  The growth in the forecast period can be attributed to regenerative medicine advancements, biologic injections, tissue engineering solutions, precision medicine, robotics-assisted surgery. Major trends in the forecast period include stem cell therapies, 3d printing in orthopedics, gene therapy for cartilage repair, personalized rehabilitation programs, telemedicine for follow-up care.

Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/cartilage-degeneration-global-market-report

Segmentation & Regional Insights
The cartilage degeneration market covered in this report is segmented –

1) By Procedure: Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell-Based Cartilage Resurfacing, Autologous Chondrocyte Implantation, Other Procedures
2) By Application: Knee, Hip, Other Applications
3) By End User: Hospitals And Specialty Clinics, Ambulatory Surgical Centers, Academic And Research Institutes

North America was the largest region in the cartilage degeneration market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cartilage degeneration  market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample_request?id=13103&type=smp

Major Driver Impacting Market Growth
The increasing prevalence of obesity is expected to propel the growth of the cartilage degeneration market going forward. Obesity is a medical condition characterized by an excessive accumulation of body fat to the extent that it may harm a person's health. Obesity can initiate and accelerate cartilage degeneration by increasing cartilage compressive forces and inflammatory cytokines. Obesity induces several pathological changes to the whole knee joint structure, including abnormal loading on the joint, joint malalignment, and muscle weakness. For instance, in May 2023, according to the Government Digital Service, a UK-based government body, in 2021–2022, around 63.8% of adults aged 18 years and over were overweight or living with obesity, an increase from 63.3% from the previous year. Further, among adults, 25.9% were estimated to be obese, which increased by 25.2% from 2020 to 2021. Therefore, the increasing prevalence of obesity is driving the growth of the cartilage degeneration market.

Key Industry Players
Major companies operating in the cartilage degeneration  market report are Johnson & Johnson Services Inc., MEDIPOST Co. Ltd., Medtronic plc, Stryker Corporation, Zimmer Biomet Holdings Inc., Smith and Nephew plc, B Braun Melsungen AG, Osiris Therapeutics Inc., Arthrex Inc., Conmed Corporation, Orthocell Ltd., Bioventus LLC, Aesculap Inc., Vericel Corporation, Anika Therapeutics Inc., Geistlich Pharma AG, MatTek Corporation, Breg Inc., Isto Biologics Inc., OrthoTrophix LLC, CellGenix GmbH, CartiHeal Inc., Cayenne Medical Inc., Collagen Solutions plc, Regentis Biomaterials Ltd., Histogen Inc., BioTime Inc., CollPlant Holdings Ltd., , ,

The cartilage degeneration market report table of contents includes:

1. Executive Summary
2. Cartilage Degeneration Market Characteristics
3. Cartilage Degeneration Market Trends And Strategies
4. Cartilage Degeneration Market - Macro Economic Scenario
5. Global Cartilage Degeneration Market Size and Growth
.

.
.
27. Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix


Explore the trending research reports from TBRC:
https://www.thebusinessresearchcompany.com/report/major-orthopedic-joint-replacement-implants-market
https://www.thebusinessresearchcompany.com/report/orthopedic-biomaterials-global-market-report
https://www.thebusinessresearchcompany.com/report/regenerative-medicine-for-cartilage-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model